(EMAILWIRE.COM, January 11, 2017 ) Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000 children under five years) every year. It can be prevented by vaccination and involves the introduction of a dead or weakened antigen into the human body. This produces lymphocytes to counter the infection and any future invasions by that antigen.

Publisher's analysts forecast the global pneumococcal vaccine market to grow at a CAGR of 13.69% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-pneumococcal-vaccine-market-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of the global pneumococcal vaccine market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent pneumococcal infections.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Publisher's report, Global Pneumococcal Vaccine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- GlaxoSmithKline (GSK)
- Merck
- Pfizer
- Sanofi

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001345912/sample

Other prominent vendors
- Abera
- AstraZeneca
- Baxter
- Beijing Minhai Biotechnology
- Biken
- Biogen
- Celgene
- Eli Lilly
- Genentech
- Genocea Biosciences
- ImmunoBiology
- Lupin
- Nuron Biotech
- Panacea Biotec (India)
- S K Chemicals
- Serum Institute of India
- Sinovac
- Valneva Austria

Market driver
- Inclusion in NIP
- For a full, detailed list, view our report

Market challenge
- Inadequate vaccine coverage
- For a full, detailed list, view our report

Market trend
- Expansion of marketing territories
- For a full, detailed list, view our report

Inquire for Report at http://www.reportsweb.com/inquiry&RW0001345912/buying

Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results